Cervical and uterine electromyograms (EMG) have been recorded from ovariectomized non-pregnant ewes. When the animals were infused with saline, the frequency of EMG events lasting less than 180 seconds was not different from those lasting more than 180 seconds. During infusion of estradiol at 100 ,ug * 24 hours-' into the maternal jugular, the frequency of events less than 180 seconds increased significantly in the myometrium and in the cervix. Contracture activity (events lasting more than 180 seconds) was not significantly different in the myometrium compared to the cervix before estradiol administration. During estradiol infusion, the contracture activity remained unchanged.
INTRODUCTION
Several groups of investigators have described the characteristics of the in vivo electromyogram (EMG) recorded from the whole myometrium and cervix in the sheep and other species in both the pregnant and non-pregnant state [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . The independence of uterine and cervical motility in the ruminant has been investigated [1] . The aim of the present study was to describe the characteristics of EMG activity of the cervix in the ovariectomized non-pregnant ewe, and to investigate the reversal of 4-amino-antipyrine (4AA) effects in the estradiol-replaced ewe by the administration of exogenous PGF2,. Cervical and myometrial EMG activity was recorded both before and during the continuous intravenous administration of estradiol, 4AA, and during PGF2a treatment. If differences exist, they may throw light on possible different regulatory mechanisms, enabling us to evaluate possible myogenic (prostacyclin:PGF2a ratio) or neurogenic factors acting on the reproductive tract.
MATERIALS AND METHODS Experimental Animals and Surgical Procedures
Four non-pregnant Rambouillet-Columbia ewes were used in the study. Four animals were used because we desired to detect at least a 15 percent change in EMG activity at (1 -= .80), the .05 significance level. Ewes were premedicated with 800-900 mg of ketamine and .5 mg of glycopyrrolate, administered intramuscularly. Under halothane anesthesia, bilateral ovariectomy was carried out in all ewes. At least five days were allowed to elapse after surgery before any infusions were started. Polyvinyl catheters (1.8 mm, outer diameter; 1.02 mm, inner diameter) were inserted into one uterine vein on each side through an entry point near the tip of the uterine horn. The catheters were passed 15 cm in the direction of the inferior vena cava so that the tip of the catheter lay in the main uterine vein. Catheters were also placed in one jugular vein and carotid artery. A fifth vascular catheter was placed in the femoral artery on one side and advanced 30 cm into the dorsal aorta.
Myometrial EMG electrodes were fabricated as described previously [2] . Four pairs of electrodes were placed; two pairs were sewn into the cervix in the region of the external os and one pair into each uterine horn near its junction with the body. In each pair, the electrodes were 2-3 mm apart.
Infusions
All vascular catheters were continuously infused with physiological saline (NaCl 0.9 percent W/V) containing 50 U heparin ml-' at a rate of .5 ml * hour-'. When estradiol was infused, it was administered to the maternal jugular vein in a solution of 2.5 percent ethanol in physiological saline (V/V) at a rate of 100 ,g estradiol 24-' in 39 ml * 24-'. When 4AA (prostaglandin synthetase inhibitor) was infused, it was administered to the maternal femoral vein in a solution of 210 * mg ml-' of saline. Fifteen mg * min-' was infused for four hours. PGF2a was prepared by dissolving .1 ml of PGF 2a (100 Ag frozen crystal dissolved in .1 ml of saline) into 4.9 ml of saline. To make up .2 .ug, 2 Aug, 5 tug, and 10 Ag preparations, the 5 (corticosteroid analysis). Four ml of blood were collected every hour in chilled heparinized tubes (S4) and EDTA-aspirin tubes (P4), centrifuged for 11 minutes, frozen with liquid nitrogen, and then stored until analysis. The EDTA-aspirin was used to prevent additional production of prostaglandins in vitro.
As described above, during simultaneous 4AA and estradiol infusion, PGF2a was administered in the femoral arterial catheter for ten minutes at .02 ,ug, .2 ,ug, .5,ug, and 1.0 jig * min-'. Samples were collected for eight hours and processed as described above. Sampling was staggered in five-minute and 30-minute intervals with, generally, a total of 19 samples per animal.
Plasma Prostaglandin Measurements
Blood samples were analyzed from three ewes. PGFM (PGF2a metabolite) and 6-keto Fla (prostacyclin metabolite) titers were determined. The methods of the assay are reported elsewhere [3] .
Recording ofEMG Signals and Data Analysis EMG signals were recorded and stored on a custom-built data acquisition system as previously described [4] . Individual epochs of activity were analyzed for duration and activity, using a two-hour running mean to set the threshold for distinguishing signal from noise, and an eight-second delimiter to determine when an epoch was completed. The EMG recordings were made continuously and analyzed in two-hour time blocks. In order to relate the present studies to our findings in the pregnant sheep, we have divided epochs of EMG activity recorded in this study to those of duration less than 180 seconds and epochs of activity greater than 180 seconds' duration [4] . Forty-eight to 72 hours of data were analyzed for each animal without estradiol administration and at least 48 hours of data during estradiol administration. Data throughout are given as means ± SD.
Statistical Analysis Methods
Data were analyzed on the basis of number of events in two-hour time intervals. Each sheep had recordings available from at least six continuous two-hour time intervals. The maximum was twenty-three. The data for individual two-hour time intervals for each sheep were averaged to give data points for the full period of study on that animal on estradiol, 4AA, and PGF2, treatment with or without estradiol. EMG activity in the cervix and myometrium was compared by the two-independent student t-test or the Wilcoxan sign rank test when variances differed greatly. Correlations between plasma prostaglandin concentrations (PGFM:6-keto Fla ratio) and PGF2a dosages were evaluated using the Pearson's correlation coefficient.
RESULTS

Short-Duration Epochs
In the absence of estradiol administration there was no significant difference in the frequency of short epochs between the cervix 76 ± 18 and the myometrium 60 ± 47 (p = .20). During estradiol infusion, the frequency of short epochs in the cervix increased from 76 ± 18 to 89 ± 22 (p < .05), while it was more significantly increased in the myometrium from 60 ± 47 to 201 ± 62 (p < .0001); also, the frequency of short epochs was significantly greater in the myometrium-201 ± 62 compared with the cervix-89 ± 22 (p < .0001). During the administration of 4AA (15 mg * min-' for four hours), the frequency of short epochs was increased insignificantly in both (Tables 1 and 2 ). Contracture Activity
In the absence of estradiol, the difference between the frequency of contractures (epochs > 180 seconds) in the cervix (2.0 ± 1.4) and in the myometrium (3.0 ± 1.4) was insignificant (p = .32). During estradiol administration, contracture frequency did not change significantly in either the myometrium-3.0 ± 1.4 to 3.3 ± 1.5 (p = .80), or in the cervix-2.0 ± 1.4 to 2.6 ± .65 (p = .53) ( Table 1) . During 4AA administration (Table 2) , however, contracture frequency decreased significantly in the myometrium-2.8 ± 1.5 to 1.0 ± .8 (p < .02) but was not changed significantly in the cervix 1.5 ± 1.6 to 1.1 ± .9 (p = .49) ( Table 2) . Activity Profile and the Administration ofPGF2a
The administration of PGF2, immediately elicited contracture-like activity in both the cervix and myometrium (Table 3 ). The cervix responded well to the .5 ,Rg * min-' while in the myometrium, contracture-like activity was elicited at .2 ,ug * min-'. After the withdrawal of the PGF2a, the electromyographic activity reappeared progressively both in the cervical and myometrical EMG recording within five to eight minutes. It was similar to that described during the control period (Fig. 1) .
When the effect of PGF2, stimulation was maximal, i.e., .5 ,tg * min-' or 1.0 ,jgmin-' as suggested by the highest level of electromyographic activity recorded, the cervix and horns displayed continuous activity for the duration of the PGF2, infusions.
In addition, the response of the cervix and myometrium appeared to be in phase. By 12 hours after the cessation of the 4AA infusion, the uterine horns and the cervix displayed regular electromyographic activity similar to those described during the control period (Fig. 3) . 
DISCUSSION
In all four ewes studied, the cervix in the non-pregnant ewe demonstrated regular EMG activity. The cervical EMG activity exhibited both similarities to, and differences from, the EMG recorded simultaneously from the myometrium. In the presence of estradiol, there was no difference in the frequency of contractures, but the myometrium demonstrated significantly more short epochs than the cervix. During 4AA treatment, the contracture activity of the myometrium significantly decreased while the cervical contracture activity remained unchanged. There was an insignificant increase in the frequency of short epochs both in the myometrium and cervix during 4AA administration. We have data, as yet unpublished, to suggest that 100 ,ug estradiol * day-' is a supramaxial dose in regard to the myometrial EMG activity. Although an n number of 4 is too small a sample size on which to base treatment effect, the reader might wonder whether or not we can accept as valid any statistical conclusions drawn on the basis of this particular small sample. [15] .
However, as a result of the low statistical power of the test (n = 3), no conclusion is warranted here. Therefore, these PGFM:6-keto Fl, trends may only provide justifica- tion for generating a hypothesis concerning the interplay between PGF2a and prostacyclin in relation to EMG activity.
In conclusion, we suggest that electrophysiological differences between the cervix and uterus may not result totally from mechanical properties or differences in blood flow but may possibly represent differences in response to regulatory mechanisms. For example, we have investigated the broad ligament (mesometrium) and found important differences in regard to the response to estradiol replacement [accepted for publication]. It is interesting to note that many of the (sympathetic postganglionic) fibers which travel via the broad ligament converge at the border of the cervix [ 1 1,12] . It is known that a-adrenergic stimulation increases myometrial contractility by further enhancing PGF2a and E2 synthesis while f-adrenergic stimulation reduces contractility by further enhancing 6-keto Fla production in pregnant human myometrial strips [ 15] .
Unfortunately, no investigations have been conducted recording simultaneous cervical and mesometrial EMG activity, measuring region;l differences in PG metabolites under adrenergic stimulation or inhibition. Also, an appropriate in vitro model should be searched for, enabling experimenters to circumvent possible systemic effects and to allow one to focus at the tissue level. Such investigations may further enable us to elucidate or describe possible mechanisms of control and/or regulation.
